These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 7729603)
21. Epidemiologic studies on the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM). Harris MI Clin Invest Med; 1995 Aug; 18(4):231-9. PubMed ID: 8549007 [TBL] [Abstract][Full Text] [Related]
22. [Info-Meeting. Pharmacologic prevention of the progression from impaired glucose tolerance to type 2 diabetes: favorable effects of metformin and acarbose]. Scheen AJ Rev Med Liege; 2001 Oct; 56(10):727-30. PubMed ID: 11765586 [TBL] [Abstract][Full Text] [Related]
23. [Drug therapy in subjects with impaired glucose tolerance]. Kawamori R; Yoshii H Nihon Rinsho; 1996 Oct; 54(10):2750-3. PubMed ID: 8914439 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of Jump Into Action: a program to reduce the risk of non-insulin dependent diabetes mellitus in school children on the Texas-Mexico border. Holcomb JD; Lira J; Kingery PM; Smith DW; Lane D; Goodway J J Sch Health; 1998 Sep; 68(7):282-8. PubMed ID: 9779403 [TBL] [Abstract][Full Text] [Related]
25. [Strategies for the prevention of elderly-onset type 2 diabetes mellitus]. Toyonaga T; Araki E Nihon Rinsho; 2006 Jan; 64(1):140-3. PubMed ID: 16408462 [TBL] [Abstract][Full Text] [Related]
26. Type 2 diabetes and obesity in adults. Whitmore C Br J Nurs; 2010 Jul 22-Aug 11; 19(14):880, 882-6. PubMed ID: 20647979 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance. Smith-Marsh D Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667 [TBL] [Abstract][Full Text] [Related]
28. [Pathophysiological conditions progressing from impaired glucose tolerance: type 2 diabetes mellitus]. Asakura T; Ito Y Nihon Rinsho; 2005 Feb; 63 Suppl 2():237-41. PubMed ID: 15779378 [No Abstract] [Full Text] [Related]
30. Prevention of type 2 Diabetes Mellitus: Potential of pharmacological agents. Samson SL; Garber AJ Best Pract Res Clin Endocrinol Metab; 2016 Jun; 30(3):357-71. PubMed ID: 27432071 [TBL] [Abstract][Full Text] [Related]
31. Primary prevention of diabetes: what can be done and how much can be prevented? Schulze MB; Hu FB Annu Rev Public Health; 2005; 26():445-67. PubMed ID: 15760297 [TBL] [Abstract][Full Text] [Related]
32. Impaired glucose tolerance: obesity and inactivity as modifiable risk factors. Taylor K Adv Nurse Pract; 2001 Dec; 9(12):59-61. PubMed ID: 12400355 [No Abstract] [Full Text] [Related]
33. An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial. O'Donoghue GM; Kennedy A; Andersen GS; Durkan E; Thybo T; Sinnott M; Nolan JJ; O'Gorman DJ Trials; 2015 Nov; 16():529. PubMed ID: 26581687 [TBL] [Abstract][Full Text] [Related]
34. Exercise or exercise and diet for preventing type 2 diabetes mellitus. Orozco LJ; Buchleitner AM; Gimenez-Perez G; Roqué I Figuls M; Richter B; Mauricio D Cochrane Database Syst Rev; 2008 Jul; (3):CD003054. PubMed ID: 18646086 [TBL] [Abstract][Full Text] [Related]
35. [Role of physical activity in the therapy and prevention of Type II diabetes mellitus]. Lehmann R; Spinas GA Ther Umsch; 1996 Dec; 53(12):925-33. PubMed ID: 9036570 [TBL] [Abstract][Full Text] [Related]